SK609, a novel dopamine D3 receptor agonist and norepinephrine transporter blocker with putative pro-cognitive actions, does not induce psychostimulant-like increases in risky choice during…

Overview of attention for article published in Psychopharmacology, December 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 9,975 followers.

RT @MatrixN_UBC: A novel dopamine receptor agonist, SK609, does not induce psychostimulant-related risky decision making. Check out the new…

@rachel_navarra_ https://t.co/C9L4eGEJDG

A novel dopamine receptor agonist, SK609, does not induce psychostimulant-related risky decision making. Check out the new #TranslationalTuesday video on the recent publication! For more information: https://t.co/enAe0NZix0 https://t.co/3iE0jvuMKs

RT @rachel_navarra_: A little break from TBI research and back to some behavioral pharmacology using the probabilistic discounting task. Ta…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.